PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404
Phase of Trial: Phase I/II
Latest Information Update: 13 Dec 2017
At a glance
- Drugs CLR 1404 I-124 (Primary)
- Indications Glioblastoma
- Focus Diagnostic use
- 08 Nov 2017 Status changed from active, no longer recruiting to discontinued.
- 26 Feb 2016 Status changed from discontinued to active, no longer recruiting as per ClinicalTrials.gov record.
- 24 Jul 2015 Status changed from active, no longer recruiting to discontinued.